Millennium to Tie the Knot With Cor on Tuesday Afternoon | GenomeWeb

NEW YORK, Feb. 12 - Shareholders for Millennium Pharmaceuticals and Cor Therapeutics on Tuesday have approved Millennium's acquisition of Cor. |

The companies said in a statement that they expect formally to tie the knot at 4:01 p.m. EST. The new company will be named Millennium Pharmaceuticals and will be headquartered in Cambridge, Mass.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.